234 related articles for article (PubMed ID: 36434403)
1. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
[TBL] [Abstract][Full Text] [Related]
2. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
[TBL] [Abstract][Full Text] [Related]
3. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
[TBL] [Abstract][Full Text] [Related]
4. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
McCrindle BW; Manlhiot C; Newburger JW; Harahsheh AS; Giglia TM; Dallaire F; Friedman K; Low T; Runeckles K; Mathew M; Mackie AS; Choueiter NF; Jone PN; Kutty S; Yetman AT; Raghuveer G; Pahl E; Norozi K; McHugh KE; Li JS; De Ferranti SD; Dahdah N;
J Am Heart Assoc; 2020 Aug; 9(15):e016440. PubMed ID: 32750313
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
[TBL] [Abstract][Full Text] [Related]
7. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Coronary Artery Aneurysm in a Chinese Pediatric Population with Kawasaki Disease at Low Risk of Intravenous Immunoglobulin Resistance: A Retrospective Cohort Study.
Liu J; Su D; Yuan P; Ye B; Qin S; Pang Y
Cardiology; 2023; 148(5):457-468. PubMed ID: 37231847
[TBL] [Abstract][Full Text] [Related]
9. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
[TBL] [Abstract][Full Text] [Related]
10. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
He XH; Zhu QL; Yuan YH; Long XD; Xia XH; Wang S; Hu C
Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):95-100. PubMed ID: 33548954
[No Abstract] [Full Text] [Related]
11. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
[TBL] [Abstract][Full Text] [Related]
12. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.
Narayan HK; Lizcano A; Lam-Hine T; Ulloa-Gutierrez R; Bainto EV; Garrido-García LM; Estripeaut D; Del Aguila O; Gómez V; Faugier-Fuentes E; Miño-León G; Beltrán S; Cofré F; Chacon-Cruz E; Saltigeral-Simental P; Martínez-Medina L; Dueñas L; Luciani K; Rodríguez-Quiroz FJ; Camacho Moreno G; Viviani T; Alvarez-Olmos MI; Marques HHS; López-Medina E; Pirez MC; Tremoulet AH;
J Pediatr; 2023 Dec; 263():113346. PubMed ID: 36775190
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.
Jiang S; Li M; Xu K; Xie Y; Liang P; Liu C; Su Q; Li B
Pediatr Res; 2024 Jan; 95(1):267-274. PubMed ID: 37670043
[TBL] [Abstract][Full Text] [Related]
15. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.
Peng Y; Cheng Z; Yi Q
Clin Exp Med; 2023 Aug; 23(4):1317-1324. PubMed ID: 36151486
[TBL] [Abstract][Full Text] [Related]
16. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
[TBL] [Abstract][Full Text] [Related]
17. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
Miyata K; Bainto EV; Sun X; Jain S; Dummer KB; Burns JC; Tremoulet AH
Arch Dis Child; 2023 Oct; 108(10):833-838. PubMed ID: 37258054
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[TBL] [Abstract][Full Text] [Related]
19. High risk of coronary artery aneurysm in Kawasaki disease.
Mossberg M; Mohammad AJ; Kahn F; Segelmark M; Kahn R
Rheumatology (Oxford); 2021 Apr; 60(4):1910-1914. PubMed ID: 33150451
[TBL] [Abstract][Full Text] [Related]
20. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
Dionne A; Burns JC; Dahdah N; Tremoulet AH; Gauvreau K; de Ferranti SD; Baker AL; Son MB; Gould P; Fournier A; Newburger JW; Friedman KG
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31048414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
